Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 16, Pages 5231-5236
Publisher
Proceedings of the National Academy of Sciences
Online
2015-04-07
DOI
10.1073/pnas.1424313112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First CDK 4/6 Inhibitor Heads to Market
- (2015) Cancer Discovery
- Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
- (2014) J. A. Sprowl et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: CDK4 Inhibitors for Cancer Therapy
- (2014) M. A. Dickson CLINICAL CANCER RESEARCH
- CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
- (2014) A. DeMichele et al. CLINICAL CANCER RESEARCH
- Regulated Cell Death in AKI
- (2014) A. Linkermann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cellular senescence: from physiology to pathology
- (2014) Daniel Muñoz-Espín et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The cancer drug that almost wasn't
- (2014) K. Garber SCIENCE
- A theoretical study of the structure and protonation of Palbociclib (PD 0332991)
- (2013) Ibon Alkorta et al. JOURNAL OF MOLECULAR STRUCTURE
- Klotho has dual protective effects on cisplatin-induced acute kidney injury
- (2013) Monica C. Panesso et al. KIDNEY INTERNATIONAL
- Renal progenitors: an evolutionary conserved strategy for kidney regeneration
- (2013) Paola Romagnani et al. Nature Reviews Nephrology
- Differentiated kidney epithelial cells repair injured proximal tubule
- (2013) T. Kusaba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Why minimal is not optimal: Driving the mammalian cell cycle—and drug discovery—with a physiologic CDK control network
- (2012) Karl A. Merrick et al. CELL CYCLE
- Regulation of Organic Cation Transport in Isolated Mouse Proximal Tubules Involves Complex Changes in Protein Trafficking and Substrate Affinity
- (2012) Denise Guckel et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Polymorphic Transporters and Platinum Pharmacodynamics
- (2012) Jason A. Sprowl et al. Drug Metabolism and Pharmacokinetics
- Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
- (2012) Patrick J. Roberts et al. JNCI-Journal of the National Cancer Institute
- Acute kidney injury
- (2012) Rinaldo Bellomo et al. LANCET
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
- (2011) Lars Anders et al. CANCER CELL
- Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
- (2011) Gottfried E. Konecny et al. CLINICAL CANCER RESEARCH
- Transporter-Mediated Drug Uptake and Efflux: Important Determinants of Adverse Drug Reactions
- (2011) O Zolk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Profiling of a Prescription Drug Library for Potential Renal Drug–Drug Interactions Mediated by the Organic Cation Transporter 2
- (2011) Yasuto Kido et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sepsis and Acute Kidney Injury
- (2011) A. Zarjou et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Repair of injured proximal tubule does not involve specialized progenitors
- (2011) B. D. Humphreys et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
- (2010) Giuliano Ciarimboli et al. AMERICAN JOURNAL OF PATHOLOGY
- Influence of Oct1/Oct2-Deficiency on Cisplatin-Induced Changes in Urinary N-Acetyl- -D-Glucosaminidase
- (2010) R. M. Franke et al. CLINICAL CANCER RESEARCH
- Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors
- (2010) Neil Johnson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Radioprotection: smart games with death
- (2010) Andrei V. Gudkov et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition
- (2010) Søren M. Johnson et al. JOURNAL OF CLINICAL INVESTIGATION
- Driving the cell cycle with a minimal CDK control network
- (2010) Damien Coudreuse et al. NATURE
- Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury
- (2010) Li Yang et al. NATURE MEDICINE
- Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
- (2010) J L Dean et al. ONCOGENE
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
- (2009) K K Filipski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
- (2009) B. A. Molitoris et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The cell cycle and acute kidney injury
- (2009) Peter M. Price et al. KIDNEY INTERNATIONAL
- Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
- (2009) A Satyanarayana et al. ONCOGENE
- Interaction of Cisplatin with the Human Organic Cation Transporter 2
- (2008) K. K. Filipski et al. CLINICAL CANCER RESEARCH
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
- (2008) N. Pabla et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More